Ads
related to: cll patient handout- FDA-Approved Treatment
Read About A Treatment For CLL
And Access Other Support Resources.
- Clinical Trial Data
See Efficacy Info On FDA-Approved
CLL Treatment.
- BTK Inhibitor Info
BTK Signaling Plays A Role In
Your Treatment. Learn More.
- How To Order Brochure
Learn How To Order A Treatment
For Chronic Lymphocytic Leukemia.
- Check Recommended Dosing
Read Dosing & Administration Info
For An Oral CLL Treatment Option.
- Efficacy Information
Download Financial Support
Resources To Share With Patients.
- FDA-Approved Treatment
Search results
Results from the WOW.Com Content Network
Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Early on, there are typically no symptoms. Later, non-painful lymph node swelling, feeling tired, fever, night sweats, or weight loss for no clear reason may occur.
B symptoms include: Fever greater than 38 °C. Pel–Ebstein fever, the classic intermittent fever associated with Hodgkin disease, occurs at variable intervals of days to weeks and lasts for 1–2 weeks before resolving. However, fever associated with lymphoma can follow virtually any pattern. Drenching sweats, especially at night.
Richter's transformation (RT), also known as Richter's syndrome, is the conversion of chronic lymphocytic leukemia (CLL) or its variant, small lymphocytic lymphoma (SLL), into a new and more aggressively malignant disease.
Aggressive NK-cell leukemia (ANKL) is a lymphoid leukemia that is a deficiency NK cells. Not very much is known about this disease due to its rarity, but it is highly aggressive. A majority of patients with NK cell leukemia die within a year of diagnosis, and for ANKL in particular, half of patients die within two months.
Rheumatology. Remitting seronegative symmetrical synovitis with pitting edema (or sometimes RS3PE) is a rare syndrome identified by symmetric polyarthritis, synovitis, acute pitting edema (swelling) of the back of the hands and/or feet, and a negative serum rheumatoid factor. [2] If no underlying disorder can be identified ( idiopathic RS3PE ...
Types. CLL/SLL, atypical CLL/SLL, non-CLL/SLL, and MBL-MZ. Monoclonal B-cell lymphocytosis (MBL) is an asymptomatic condition in which individuals have increased blood levels of particular subtypes of monoclonal lymphocytes (i.e. an aberrant and potentially malignant group of lymphocytes produced by a single ancestral cell).
Ads
related to: cll patient handout